Treatment of acute myocardial infarction: Does the type of hospital make a difference ?

Indian Heart Journal

Volumn 51, Issue 2, 1999, Pages 161-166

  George, Elizabeth ^a,b   Hunsberger, Sally ^a   Savitha, D ^a   Pais, Prem ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; LIDOCAINE; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; NIFEDIPINE; PETHIDINE; VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; DRUG UTILIZATION; FEMALE; FIBRINOLYTIC THERAPY; HOSPITALIZATION; HUMAN; MALE; PRIVATE HOSPITAL; PUBLIC HOSPITAL; TEACHING HOSPITAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOLOGY SERVICE, HOSPITAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; INDIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0033000101     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mckeigue PM, Marmot MG. Mortality from coronary heart disease in Asian community in London. Br Med J 1988; 297: 903
2. Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 1992; 70: 945-949
3. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. Br Med J 1991; 302: 560-564
4. Dhawan J. Coronary heart disease risks in Indians. Curr Opin Lipidol 1996; 7: 196-198
5. Gupta R, Gupta VP. Meta analysis of coronary heart disease prevalence in India. Indian Heart J 1996; 48: 241-245
6. Kutty VR, Balakrishnan KG, Jayashree AK, Thomas J. Prevalence of coronary heart disease in the rural population of Thiruvananthapuram district, Kerala, India. Intern J Cardiol 1993; 39: 59-70
7. ISIS-2 (Second International Study of Infarct Survival) Collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360
8. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682
9. ISIS-4: A randomised factorial trial comparing early oral captopril, oral mononitrate and intravenous magnesium sulphate among 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-685
10. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russel RO, Smith EE III, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328-1428
11. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. II - The design and analysis of Cohort Studies, International Agency for Research on Cancer, Lyon. IARC Sci Publ 1987; 82: 1-406
12. Krumholz HM, Murillo JE, Chen J, Vaccarino V, Radford MJ, Ellerbeck EF, Wang Y. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA 1997; 277: 1683-1688
13. Tincani E, Mazzoli V, Bondi M. Management of acute myocardial infarction in the experience of a community hospital: A prospective study. Minerva Cardioangiol 1997; 45: 335-347
14. Danchin N, Vaur L, Genes N, Renault M, Ferrieres J, Etienne S, Cambou JP. Management of acute myocardial infarction in intensive care units in 1995: A nationwide French survey of practice and early hospital results. J Am Coll Cardiol 1997; 30: 1598-1605
15. European Secondary Prevention Study Group. Translation of clinical trials into practice: A European population based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996; 347: 1203-1207
16. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, Rubison RM, Tienfenbrunn AJ, Weaver WD. Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the national registry of myocardial infarction. Circulation 1994; 90: 2103-2114
17. Tsuyuki RT, Gill S, Hilton JD. Patterns of practice analysis for acute myocardial infarction. Can J Cardiol 1994; 10: 891-896
18. Oka RK, Fortmann SP, Varady AN. Differences in treatment of acute myocardial infarction by sex, age and other factors (the Stanford Five-City Project). Am J Cardiol 1996; 78: 861-865
19. Fernando PB, Ferreira A, Dias P, Moura L, Cortez M, Capucho R, Maciel MJ, Brandao F, Gomer MC. Pharmacologic treatment of acute myocardial infarction: Two large clinical trials at a central hospital. Rev Port Cardiol 1996; 15: 617-630
20. Anand SS, Pais P, Pogue J, Yusuf S. A comparison of practice patterns for acute myocardial infarction between hospitals in Canada and India. Indian Heart J 1997; 49: 35-41
21. Sakethou BB, Conte FJ, Noris M, Tilkemeier P, Miller G, Forman DE, Cannistra L, Leavitt J, Sharma SC, Garber C, Parisi AF. Emergency department use of aspirin in patients with possible acute myocardial infarction. Ann Intern Med 1997; 127: 126-129